Succinic Acid

Succinic Acid

SCHEMBL6737578

O=C(O)CCC(=O)O.O=C(O)CCC(=O)O.O=C([O-])CCC(=O)[O-].[Li+].[Li+]

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.60
EGLN1 Q9GZT9 3/20 0.60
ALKBH5 Q6P6C2 1/20 0.60
SUCNR1 Q9BXA5 1/20 0.60
MAPK1 P28482 1/20 0.53
SLC13A3 Q8WWT9 1/20 0.53
OR51E2 Q9H255 1/20 0.53
FFAR3 O14843 3/20 0.45
HDAC3 O15379 3/20 0.45
HDAC1 Q13547 3/20 0.45
HDAC2 Q92769 3/20 0.45
HDAC8 Q9BY41 3/20 0.45
SLC15A2 Q16348 1/20 0.45
SLC22A6 Q4U2R8 1/20 0.44
TSHR P16473 2/20 0.42
NFKB1 P19838 1/20 0.42
PMP22 Q01453 1/20 0.42
KDM4E B2RXH2 2/20 0.41
KDM5C P41229 2/20 0.41
PHF8 Q9UPP1 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL105373 1.00
Succinic Acid SCHEMBL7096340 0.97 LMNA (0.56) LMNAEGLN1ALKBH5SUCNR1MAPK1
Succinic Acid SCHEMBL11666802 0.93 LMNA (0.60) LMNAEGLN1ALKBH5SUCNR1MAPK1
Succinic Acid SCHEMBL9508104 0.93 LMNA (0.60) LMNAEGLN1ALKBH5SUCNR1MAPK1
Succinic Acid SCHEMBL7116400 0.93
Succinic Acid SCHEMBL8620669 0.93
Succinic Acid SCHEMBL155053 0.93 LMNA (0.60) LMNAEGLN1ALKBH5SUCNR1MAPK1
Succinic Acid SCHEMBL151456 0.93 LMNA (0.60) LMNAEGLN1ALKBH5SUCNR1MAPK1
Succinic Acid SCHEMBL21776708 0.93 LMNA (0.60) LMNAEGLN1ALKBH5SUCNR1MAPK1
Succinic Acid SCHEMBL18889846 0.93 LMNA (0.60) LMNAEGLN1ALKBH5SUCNR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040039211-A1 Tetrapyrroles DUKE UNIVERSITY AND NATIONAL JEWISH MEDICAL AND RESEARCH CENTER 2004-02-26 US disclosed
EP-1320532-A1 TETRAPYRROLES DUKE UNIVERSITY (US) 2003-06-25 EP disclosed
US-20030069281-A1 Tetrapyrroles GOODNOW CAPITAL, L.L.C. 2003-04-10 US disclosed
WO-2001096345-A1 TETRAPYRROLES DUKE UNIVERSITY (US) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069281-A1 Tetrapyrroles PPOX, TXNRD2, PRDX5 LMNA 4336/4885EGLN1 2473/4885ALKBH5 2385/4885
US-20040039211-A1 Tetrapyrroles PPOX, TXNRD2, PRDX5 LMNA 4336/4885EGLN1 2473/4885ALKBH5 2385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.